Literature DB >> 3085743

Carrier detection in hemophilia A: a cooperative international study. I. The carrier phenotype.

J B Graham, C R Rizza, J Chediak, P M Mannucci, E Briët, R Ljung, C K Kasper, E M Essien, P P Green.   

Abstract

Eight laboratories in six countries cooperated to clarify several issues concerning the phenotypes of heterozygous carriers of hemophilia "A." Plasma levels of factor VIII (F.VIII:C, formerly VIII:C) and von Willebrand factor (VWF:Ag, formerly VIIIR:Ag) of carriers and normal women were determined by various "in-house" methods; a single lyophilized plasma standard was used for all assays. Analysis of the collated data from 336 carriers (296 obligatory carriers and 40 sporadic carriers) and 137 normal women showed that there was no difference in the F.VIII:C levels of "paternal" carriers (women who had obtained the abnormal gene from their fathers) and "maternal" carriers. Neither was there a difference in the VWF:Ag levels of normal women and either type of carrier. Age was found to have a significant effect on both F.VIII:C and VWF:Ag, values being higher at very young and very old ages, the minima occurring in the 25- to 30-year range. ABO blood type had a striking effect. Women of types A, B, and AB (designated non-O in the study), both normals and carriers, had significantly higher levels of both factors than did women of type O. Analysis by laboratories showed that differences in mean levels of both factors between laboratories were highly significant. It was concluded that age, ABO blood type, and laboratory variation should be taken into account in carrier detection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3085743

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  The Bleeding Assessment Tool and laboratory data in the characterisation of a female with inherited haemophilia A.

Authors:  Viviana Daidone; Eva Galletta; Antonella Bertomoro; Alessandra Casonato
Journal:  Blood Transfus       Date:  2016-11-15       Impact factor: 3.443

2.  Women and girls with haemophilia receiving care at specialized haemophilia treatment centres in the United States.

Authors:  Connie H Miller; J Michael Soucie; Vanessa R Byams; Amanda B Payne; Robert F Sidonio; Tyler W Buckner; Christopher J Bean
Journal:  Haemophilia       Date:  2021-09-04       Impact factor: 4.263

3.  Haemophilia A: carrier detection by DNA analysis.

Authors:  R Schwaab; J Oldenburg; M Higuchi; M Ludwig; L Kochhan; J Horst; H H Brackmann; H Egli; K Olek
Journal:  Blut       Date:  1988-08

Review 4.  The contribution of DNA analysis to carrier detection and prenatal diagnosis of hemophilia A and B.

Authors:  A H Bröcker-Vriends; E Bakker; H H Kanhai; G J van Ommen; P H Reitsma; J J van de Kamp; E Briët
Journal:  Ann Hematol       Date:  1992-01       Impact factor: 3.673

5.  The Malmö polymorphism of coagulation factor IX, an immunologic polymorphism due to dimorphism of residue 148 that is in linkage disequilibrium with two other F.IX polymorphisms.

Authors:  J B Graham; D B Lubahn; S T Lord; J Kirshtein; I M Nilsson; A Wallmark; R Ljung; L D Frazier; J L Ware; S W Lin
Journal:  Am J Hum Genet       Date:  1988-04       Impact factor: 11.025

6.  A cross-sectional study of bleeding phenotype in haemophilia A carriers.

Authors:  Allison Paroskie; Dave Gailani; Michael R DeBaun; Robert F Sidonio
Journal:  Br J Haematol       Date:  2015-04-01       Impact factor: 6.998

Review 7.  Genetic causes of haemophilia in women and girls.

Authors:  Connie H Miller; Christopher J Bean
Journal:  Haemophilia       Date:  2020-12-13       Impact factor: 4.263

8.  Total hip arthroplasty for a woman with hemophilia A -case report.

Authors:  Akio Kanda; Kazuo Kaneko; Osamu Obayashi; Atsuhiko Mogami; Itaru Morohashi
Journal:  Ann Med Surg (Lond)       Date:  2019-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.